MONTVALE, N.J., March 29 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. , a biopharmaceutical company, today announced that Jim Sulat, President and Chief Executive Officer, will provide a company update at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference on Wednesday, April 5th, at 3:45 p.m. E.T., at the Millennium Broadway Hotel in New York City.
Interested parties may access a live audio webcast of the presentation by visiting the Investor Relations section of Memory Pharmaceuticals’ website at http://www.memorypharma.com. An archived version of the webcast will be available at the same location through April 12, 2006.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression, bipolar disorder, vascular dementia, mild cognitive impairment, Parkinson’s disease and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, Vice President, Legal Affairs, +1-201-802-7249;Laura Perry Stern Investor Relations, Inc., +1-212-362-1200
Web site: http://www.memorypharma.com/
